Chrysanthi Paranavitana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chrysanthi Paranavitana has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Antoaneta Vladimirova
Ingenuity Systems; Redwood City CA USA
1 shared publication- Luis DaSilva
Center for Aerobiological Sciences; US Army Medical Research Institute of Infectious Diseases (USAMRIID); Frederick MD USA
1 shared publication Mahendran Velauthapillai
Department of Computer Sciences; Georgetown University; Washington DC USA
1 shared publication- Mikeljon P. Nikolich
Wound Infections Department, Bacterial Diseases Branch, Center for Infectious Disease Research, Walter Reed Army Institute of Research
1 shared publication - Phillip R. Pittman
Division of Medicine, US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011, USA
1 shared publication
Latest Publications
- Open Access
- 23 January 2014
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 70 (2) , 141-152
Transcriptional profiling of recall responses toFrancisellalive vaccine strain
Global gene expression profile changes were monitored in human peripheral blood mononuclear cells (PBMCs) after challenge with the live vaccine strain (LVS) of Francisella tularensis. Because these PBMCs were from individuals previously immunized with LVS, stimulating these cells with LVS should activate memory responses. The Ingenuity Pathway Analysis tool identified pathways, functions, and networks associated with this in vitro recall response, including novel pathways triggered by the memory response. Dendritic cell (DC) maturation was the most significant among the more than 25 relevant pathways discovered. Interleukin 15, granulocyte–macrophage colony-stimulating factor, and triggering receptor expressed on myeloid cells 1 signaling pathways were also significant. Pathway analysis indicated that Class 1 antigen presentation may not be optimal with LVS vaccination. The top three biological functions were antigen presentation, cell-mediated and humoral immune responses. Network analysis revealed that the top network associated with these functions had IFNγ and TNFα in central interactive positions. Our results suggest that DC maturation is a key factor in the recall responses and that more effective antigen processing and presentation is needed for cytotoxic T lymphocyte responses. Taken together, these considerations are critical for future tularemia vaccine development studies.
- 23 January 2014
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 70 (2) , 141-152
Open AccessTranscriptional profiling of recall responses toFrancisellalive vaccine strain
Global gene expression profile changes were monitored in human peripheral blood mononuclear cells (PBMCs) after challenge with the live vaccine strain (LVS) of Francisella tularensis. Because these PBMCs were from individuals previously immunized with LVS, stimulating these cells with LVS should activate memory responses. The Ingenuity Pathway Analysis tool identified pathways, functions, and networks associated with this in vitro recall response, including novel pathways triggered by the memory response. Dendritic cell (DC) maturation was the most significant among the more than 25 relevant pathways discovered. Interleukin 15, granulocyte–macrophage colony-stimulating factor, and triggering receptor expressed on myeloid cells 1 signaling pathways were also significant. Pathway analysis indicated that Class 1 antigen presentation may not be optimal with LVS vaccination. The top three biological functions were antigen presentation, cell-mediated and humoral immune responses. Network analysis revealed that the top network associated with these functions had IFNγ and TNFα in central interactive positions. Our results suggest that DC maturation is a key factor in the recall responses and that more effective antigen processing and presentation is needed for cytotoxic T lymphocyte responses. Taken together, these considerations are critical for future tularemia vaccine development studies.